|
Market Closed -
Nasdaq Stockholm
17:00:00 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.210 SEK | -2.21% |
|
+1.84% | -2.21% |
| 04-21 | Larkberget to carry out rights issue of units totaling SEK 14.9 mln | RE |
| 04-17 | Larkberget net asset value per share at SEK 3.04 | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBIGENE AB | Bio Therapeutic Drugs | -2.21% | +1.84% | -2.21% | -9.43% | -73.05% | 4.6M |  |  | |
- Stock Market
- Stocks
- LARK Stock
- Charts CombiGene AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
